JUNFYO
LIVE

Serial Number

79429969

Owner

Bausch Health Ireland Limited

Attorney

Jeremy Blackowicz

Filing Date

Jul 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

JUNFYO Trademark

Serial Number: 79429969

JUNFYO is a trademark filed by Bausch Health Ireland Limited on July 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bausch Health Ireland Limited

3013 Lake Drive Citywest Business Campus

Entity Type: 99

Trademark Details

Filing Date

July 11, 2025

Registration Date

Not Registered

Published for Opposition

February 17, 2026

Goods & Services

pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of viral diseases.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
REFUSAL PROCESSED BY IB
Jan 29, 2026 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 9, 2026 RFRR
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Dec 18, 2025 RHRD
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 14, 2025 REPR